PMID- 3193449 OWN - NLM STAT- MEDLINE DCOM- 19890110 LR - 20131121 IS - 0047-2565 (Print) IS - 0047-2565 (Linking) VI - 17 IP - 4 DP - 1988 TI - Comparative teratogenicity of triamcinolone acetonide and dexamethasone in the rhesus monkey (Macaca mulatta). PG - 195-203 AB - Pregnant rhesus macaques were treated with 0.5 or 2.5 mg/kg triamcinolone acetonide (TAC) or 1.0 or 10.0 mg/kg dexamethasone sodium phosphate (DEX) between 20 and 50 gestational days (GD). Treatment with TAC at 2.5 mg/kg resulted in a fetal loss of 71%; 3/5 recovered fetuses displayed an encephalocele or meningocele. All other treatment groups displayed minor cranial skeletal abnormalities consistent with glucocorticoid-mediated teratogenesis. DEX was shown to have a lower teratogenic potential than TAC in this species. FAU - Jerome, C P AU - Jerome CP AD - Department of Comparative Medicine, Bowman Gray School of Medicine, Wake Forest University, Winston Salem, NC. FAU - Hendrickx, A G AU - Hendrickx AG LA - eng GR - RR00169/RR/NCRR NIH HHS/United States PT - Comparative Study PT - Journal Article PT - Research Support, U.S. Gov't, P.H.S. PL - Denmark TA - J Med Primatol JT - Journal of medical primatology JID - 0320626 RN - 7S5I7G3JQL (Dexamethasone) RN - F446C597KA (Triamcinolone Acetonide) SB - IM MH - Abnormalities, Drug-Induced/pathology/*veterinary MH - Animals MH - Body Weight MH - Brain/pathology MH - Cephalometry MH - Dexamethasone/*adverse effects MH - Encephalocele/chemically induced MH - Female MH - *Macaca MH - *Macaca mulatta MH - Meningocele/chemically induced MH - Monkey Diseases/*pathology MH - Organ Size MH - Pregnancy MH - Pregnancy Outcome/veterinary MH - Skull/abnormalities MH - Triamcinolone Acetonide/*adverse effects EDAT- 1988/01/01 00:00 MHDA- 1988/01/01 00:01 CRDT- 1988/01/01 00:00 PHST- 1988/01/01 00:00 [pubmed] PHST- 1988/01/01 00:01 [medline] PHST- 1988/01/01 00:00 [entrez] PST - ppublish SO - J Med Primatol. 1988;17(4):195-203.